Immune-mediated positive selection drives human immunodeficiency virus type 1 molecular variation and predicts disease duration

Journal of Virology

Volumn 76, Issue 22, 2002, Pages 11715-11720

  Ross, Howard A ^a   Rodrigo, Allen G ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ANTIGEN RECOGNITION; ARTICLE; CHILD; CLINICAL ARTICLE; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE DURATION; ENVELOPE GENE; GENETIC VARIABILITY; HELPER CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HYPOTHESIS; IMMUNE RESPONSE; IMMUNITY; LONGITUDINAL STUDY; NUCLEOTIDE SEQUENCE; PREDICTION; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; UNINDEXED SEQUENCE;

EID: 0036828069     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.76.22.11715-11720.2002     Document Type: Article

References (50)

1. Alkhatib, G., C. Combadiere, C. C. Broder, Y. Feng, P. E. Kennedy, P. M. Murphy, and E. A. Berger. 1996. CC CKR5: A RANTES, MIP-1α, MIP-1β receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 272:1955-1958.
2. Bonhoeffer, S., E. C. Holmes, and M. A. Nowak. 1995. Causes of HIV diversity. Nature 376:125.
3. Chesebro, B., K. Wehrly, J. Nishio, and S. Perryman. 1996. Mapping of independent V3 envelope determinants of human immunodeficiency virus type 1 macrophage tropism and syncytium formation in lymphocytes. J. Virol. 70:9055-9059.
4. Choe, H., M. Farzan, Y. Sun, N. Sullivan, B. Rollins, P. D. Ponath, L. Wu, C. R. Mackay, G. LaRosa, W. Newman, N. Gerard, C. Gerard, and J. Sodroski. 1996. The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 85:1135-1148.
5. Deng, H., R. Liu, W. Ellmeier, S. Choe, D. Unutmaz, M. Burkhart, P. Di Marzio, S. Marmon, R. E. Sutton, C. M. Hill, C. B. Davis, S. C. Peiper, T. J. Schall, D. R. Littman, and N. R. Landau. 1996. Identification of a major coreceptor for primary isolates of HIV-1. Nature 381:661-666.
6. Doranz, B. J., J. Rucker, Y. Yi, R. J. Smyth, M. Samson, S. C. Peiper, M. Parmentier, R. G. Collman, and R. W. Doms. 1996. A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors. Cell 85:1149-1158.
7. + cells is mediated by the chemokine receptor CC-CKR-5. Nature 381:667-673.
8. Feng, Y., C. C. Broder, P. E. Kennedy, and E. A. Berger. 1996. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 272:872-877.
9. Fenoglio, D., G. Li Pira, L. Lozzi, L. Bracci, D. Saverino, P. Terranova, L. Bottone, S. Lantero, A. Megiovanni, A. Merlo, and F. Manca. 2000. Natural analogue peptides of an HIV-1 gp120 T-helper epitope antagonize response of gp120-specific human CD4 T-cell clones. J. Acquir. Immune Defic. Syndr. 23:1-7.
10. Goudsmit, J., C. Debrouck, R. H. Meloen, L. Smit, M. Bakker, D. M. Asher, A. V. Wolff, C. J. Gibbs, Jr., and D. C. Gajdusek. 1988. Human immunodeficiency virus type 1 neutralization epitope with conserved architecture elicits early type-specific antibodies in experimentally infected chimpanzees. Proc. Natl. Acad. Sci. USA 85:4478-4482.
11. Halapi, E., T. Leitner, M. Jansson, G. Scarlatti, P. Orlandi, A. Plebani, L. Romiti, J. Albert, H. Wigzell, and P. Rossi. 1997. Correlation between HIV sequence evolution, specific immune response and clinical outcome in vertically infected infants. AIDS 11:1709-1717.
12. Holmes, E. C., L. Q. Zhang, P. Simmonds, C. A. Ludlam, and A. J. L. Brown. 1992. Convergent and divergent sequence evolution in the surface envelope glycoprotein of human immunodeficiency virus type 1 within a single infected patient. Proc. Natl. Acad. Sci. USA 89:4835-4839.
13. Huelsenbeek, J. P., and B. Rannala. 1997. Phylogenetic methods come of age: Testing hypotheses in an evolutionary context. Science 276:227-232.
14. Javaherian, K., A. J. Langlois, C. McDanal, K. L. Ross, L. I. Eckler, C. L. Jellis, A. T. Profy, J. R. Rusche, D. P. Bolognesi, S. D. Putney, et al. 1989. Principal neutralizing domain of the human immunodeficiency virus type 1 envelope protein. Proc. Natl. Acad. Sci. USA 86:6768-6772.
15. Kalams, S. A., and B. D. Walker. 1998. The critical need for CD4 help in maintaining effective cytotoxic T lymphocyte responses. J. Exp. Med. 188:2199-2204.
16. Kalams, S. A., and B. D. Walker. 2002. HIV vaccines 2000: Prospects and challenges, p. 481-509. In E. A. Emini (ed.), The Human Immunodeficiency Virus: Biology, Immunology, and Therapy. Princeton University Press, Princeton, N.J.
17. Kaslow, R. A., D. G. Ostrow, R. Detels, J. P. Phair, B. F. Polk, and C. R. Rinaldo, Jr. 1987. The Multicenter AIDS Cohort Study: Rationale, organization, and selected characteristics of the participants. Am. J. Epidemiol. 126:310-318.
18. Korber, B., C. Brander, B. F. Haynes, R. Koup, C. Kuiken, J. P. Moore, B. D. Walker, and D. I. Watkins (ed.). 2002. HIV molecular immunology database 2001. Theoretical Biology and Biophysics, Los Alamos National Laboratory, Los Alamos, N.Mex.
19. Kuiken, C. L., B. Foley, B. Hahn, B. Korber, F. McCutchan, P. A. Marx, J. W. Mellors, J. I. Mullins, J. Sodroski, and S. Wolinksy (ed.). 2000. Human Retroviruses and AIDS 2000: A Compilation and Analysis of Nucleic Acid and Amino Acid Sequences. Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, Los Alamos, N.Mex.
20. Leigh Brown, A. J. 1997. Analysis of HIV-1 env gene sequences reveals evidence for a low effective number in the viral population. Proc. Natl. Acad. Sci. USA 94:1862-1865.
21. Lukashov, V. V., C. L. Kuiken, and J. Goudsmit. 1995. Intrahost human immunodeficiency virus type 1 evolution is related to length of the immunocompetent period. J. Virol. 69:6911-6916.
22. Maddon, P. J., A. J. Dalgleish, J. S. McDougal, P. R. Clapham, R. A. Weiss, and R. Axel. 1986. The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain. Cell 47:333-348.
23. Mansky, L. M. 1996. Forward mutation rate of human immunodeficiency virus type 1 in a T lymphoid cell line. AIDS Res. Hum. Retrovir. 12:307-314.
24. McMichael, A. J., and R. E. Phillips. 1997. Escape of human immunodeficiency virus from immune control. Annu. Rev. Immunol. 15:271-296.
25. Moore, C. B., M. John, I. R. James, F. T. Christiansen, C. S. Witt, and S. A. Mallal. 2002. Evidence of HIV-1 adaptation to HLA-restricted immune responses at a population level. Science 296:1439-1443.
26. Nei, M., and T. Gojobori. 1986. Simple methods for estimating the numbers of synonymous and nonsynonymous nucleotide substitutions. Mol. Biol. Evol. 3:418-426.
27. Nielsen, R., and Z. Yang. 1998. Likelihood models for detecting positively selected amino acid sites and applications to the HIV-1 envelope gene. Genetics 148:929-936.
28. Nowak, M. A., J. P. Anderson, M. C. Boerlijst, S. Bonhoeffer, R. M. May, and A. J. McMichael. 1996. HIV-1 evolution and disease progression. Science 274:1008-1010.
29. Nowak, M. A., and C. R. M. Bangham. 1996. Population dynamics of immune responses to persistent viruses. Science 272:74-79.
30. Nowak, M. A., R. M. May, R. E. Phillips, S. Rowland-Jones, D. G. Lalloo, S. McAdam, P. Klenerman, B. Köppe, K. Sigmund, C. R. M. Bangham, and A. J. McMichael. 1995. Antigenic oscillations and shifting immunodominance in HIV-1 infections. Nature 375:606-611.
31. Rambaut, A. 2000. Estimating the rate of molecular evolution: Incorporating non-contemporaneous sequences into maximum likelihood phylogenies. Bioinformatics 16:395-399.
32. Rodrigo, A. G., E. W. Hanley, P. C. Goracke, and G. H. Learn, Jr. 2001. Sampling and processing HIV molecular sequences: A computational evolutionary biologist's perspective, p. 1-17. In A. G. Rodrigo and G. H. Learn, Jr. (ed.), Computational and Evolutionary Analysis of HIV Molecular Sequences. Kluwer Academic Publishers, Boston, Mass.
33. Rodrigo, A. G., and J. I. Mullins. 1996. Human immunodeficiency virus type 1 molecular evolution and the measure of selection. AIDS Res. Hum. Retrovir. 12:1681-1685.
34. Shankarappa, R., J. B. Margolick, S. J. Gange, A. G. Rodrigo, D. Upchurch, H. Farzadegan, P. Gupta, C. R. Rinaldo, G. H. Learn, X. He, X.-L. Huang, and J. I. Mullins. 1999. Consistent viral evolutionary changes associated with the progression of human immunodeficiency virus type 1 infection. J. Virol. 73:10489-10502.
35. Stein, B. S., S. D. Gowda, J. D. Lifson, R. C. Penhallow, K. G. Bensch, and E. G. Engelman. 1987. pH-independent HIV entry into CD4-positive T cells via virus envelope fusion to the plasma membrane. Cell 49:659-668.
36. Swofford, D. L. 2001. PAUP*: Phylogenetic Analysis Using Parsimony (*and Other Methods). Sinauer, Sunderland, Mass.
37. Swofford, D. L., G. J. Olsen, P. C. Waddell, and D. M. Hillis. 1996. Phylogenetic inference, p. 407-514. In D. M. Hillis, C. Moritz, and B. K. Marble (ed.), Molecular Systematics. Sinauer Associates, Sunderland, Mass.
38. Thompson, J. D., T. J. Gibson, F. Plewniak, F. Jeanmougin, and D. G. Higgins. 1997. The ClustalX windows interface: Flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res. 24:4876-4882.
39. Tsubota, H., C. I. Lord, D. I. Watkins, C. Morimoto, and N. L. Letvin. 1989. A cytotoxic T lymphocyte inhibits acquired immunodeficiency syndrome virus replication in peripheral blood lymphocytes. J. Exp. Med. 169:1421-1434.
40. + lymphocytes can control HIV infection in vitro by suppressing virus replication. Science 234:1563-1566.
41. Wilson, C. C., B. Palmer, S. Southwood, J. Sidney, Y. Higashimoto, E. Appella, R. Chesnut, A. Sette, and B. D. Livingston. 2001. Identification and antigenicity of broadly cross-reactive and conserved human immunodeficiency virus type 1-derived helper T-lymphocyte epitopes. J. Virol. 75:4195-4207.
42. Wodarz, D., and M. A. Nowak. 2000. CD8 memory, immunodominance, and antigenic escape. Eur. J. Immunol. 30:2704-2712.
43. Wodarz, D., K. M. Page, R. A. Arnaout, A. R. Thomsen, J. D. Lifson, and M. A. Nowak. 2000. A new theory of cytotoxic T-lymphocyte memory: Implications for HIV treatment. Phil. Trans. R. Soc. London B 355:329-343.
44. Wolfs, T. F., G. Zwart, M. Bakker, M. Valk, C. L. Kuiken, and J. Goudsmit. 1991. Naturally occurring mutations within HIV-1 V3 genomic RNA lead to antigenic variation dependent on a single amino acid substitution. Virology 185:190-205.
45. Wolinsky, S. M., B. T. M. Korber, A. U. Neumann, M. Daniels, K. J. Kunstman, A. J. Whetsell, M. R. Furtado, Y. Cao, D. D. Ho, J. T. Safrit, and R. A. Koup. 1996. Adaptive evolution of human immunodeficiency virus-type 1 during the natural course of infection. Science 272:537-542.
46. Yamaguchi, Y., and T. Gojobori. 1997. Evolutionary mechanisms and population dynamics of the third variable envelope region of HIV within single hosts. Proc. Natl. Acad. Sci. USA 94:1264-1269.
47. Yamaguchi-Kabata, Y., and T. Gojobori. 2000. Reevaluation of amino acid variability of the human immunodeficiency virus type 1 gp120 envelope glycoprotein and prediction of new discontinuous epitopes. J. Virol. 74:4335-4350.
48. Yang, Z. 1997. PAML: A program package for phylogenetic analysis by maximum likelihood. Comput. Appl. Biol. Sci. 13:555-556.
49. Yang, Z., R. Nielsen, N. Goldman, and A.-M. Krabbe Pedersen. 2000. Codon-substitution models for heterogeneous selection pressure at amino acid sites. Genetics 155:431-449.
50. Zanotto, P. M. A., E. G. Kallas, R. F. de Souza, and E. C. Holmes. 1999. Genealogical evidence for positive selection in the nef gene of HIV-1. Genetics 153:1077-1089.